ScholarIQanswers from OpenAlex & ORCID
Annette Bruchfeld
ResearcherPublications, citations & collaboration network
Annette Bruchfeld is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Annette Bruchfeld have?
ScholarIQindexed works
Annette Bruchfeld has 275 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Annette Bruchfeld have?
ScholarIQcitation count
Annette Bruchfeld has 10,219 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Annette Bruchfeld?
ScholarIQh-index
Annette Bruchfeld has an h-index of 50 in OpenAlex.
What is the i10-index of Annette Bruchfeld?
ScholarIQi10-index
Annette Bruchfeld has an i10-index of 133 in OpenAlex.
What is the ORCID of Annette Bruchfeld?
ScholarIQorcid
The ORCID for Annette Bruchfeld is on the source record.
What is the OpenAlex record for Annette Bruchfeld?
ScholarIQopenalex
The OpenAlex for Annette Bruchfeld is on the source record.
What are the most-cited papers on Annette Bruchfeld?
ScholarIQmost cited works
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Paul Lyons, Tim F. Rayner, Sapna Trivedi, Julia U. Holle, Richard A. Watts, David Jayne, Bo Baslund, Paul Brenchley, Annette Bruchfeld, Afzal Chaudhry, Jan Willem Cohen Tervaert, Panos Deloukas, Conleth Feighery, Wolfgang L. Gross, Loı̈c Guillevin, Iva Gunnarsson, Lorraine Harper, Zdenka Hrušková, Mark A. Little, Davide Martorana, Thomas Neumann, Sophie Ohlsson, Sandosh Padmanabhan, Charles D. Pusey, Alan D. Salama, Jan‐Stephan Sanders, Caroline O.S. Savage, Mårten Segelmark, Coen A. Stegeman, Vladimı́r Tesař, Augusto Vaglio, Stefan Wieczorek, Benjamin Wilde, Jochen Zwerina, Andrew J. Rees, David Clayton, Kenneth G. C. Smith
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
David Roth, David R. Nelson, Annette Bruchfeld, AnnMarie Liapakis, Marcelo Silva, Howard Monsour, Paul Martin, Stanislas Pol, María‐Carlota Londoño, Tarek Hassanein, Philippe J. Zamor, Eli Zuckerman, Shuyan Wan, Beth Jackson, Bach-Yen Nguyen, Michael Robertson, Eliav Barr, Janice Wahl, Wayne Greaves
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David Jayne, Annette Bruchfeld, Lorraine Harper, Matthias Schaier, Michael Venning, Patrick Hamilton, Volker Burst, Franziska Grundmann, Michel Jadoul, István Szombati, Vladimı́r Tesař, Mårten Segelmark, Antonia Potarca, Thomas J. Schall, Pirow Bekker, for the CLEAR Study Group
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
Lorraine Harper, Matthew D. Morgan, Michael Walsh, Peter Höglund, Kerstin Westman, Oliver Floßmann, Vladimı́r Tesař, Phillipe Vanhille, Kirsten de Groot, Raashid Luqmani, Luis Felipe Flores-Suárez, Richard A. Watts, Charles D. Pusey, Annette Bruchfeld, Niels Rasmussen, Daniël Blockmans, Caroline O. S. Savage, David Jayne
ELEVATED HIGH-MOBILITY GROUP BOX 1 LEVELS IN PATIENTS WITH CEREBRAL AND MYOCARDIAL ISCHEMIA
Richard S. Goldstein, Margot Gallowitsch‐Puerta, Lihong Yang, Mauricio Rosas‐Ballina, Jared M. Huston, Christopher J. Czura, David C. Lee, Mae F. Ward, Annette Bruchfeld, Haichao Wang, Martin Lesser, Adam L. Church, A. Litroff, Andrew E. Sama, Kevin J. Tracey